American Journal of Kidney Diseases
Volume 51, Issue 6 , Pages 885-892, June 2008

Association of Hepatitis C Virus Infection With Prevalence and Development of Kidney Disease

  • Sharon M. Moe, MD

      Affiliations

    • Indiana University School of Medicine, Indianapolis, IN
    • Roudebush VAMC, Indianapolis, IN
    • Corresponding Author InformationAddress correspondence to Sharon M. Moe, MD, Professor of Medicine, Vice-Chair for Research, Department of Medicine, Indiana University School of Medicine, 1001 W 10th St, OPW 526, Indianapolis, IN 46202.
  • ,
  • A.J. Pampalone, MD

      Affiliations

    • Indiana University School of Medicine, Indianapolis, IN
  • ,
  • Susan Ofner, MS

      Affiliations

    • Indiana University School of Medicine, Indianapolis, IN
  • ,
  • Marc Rosenman, MD

      Affiliations

    • Indiana University School of Medicine, Indianapolis, IN
    • Regenstrief Institute, Indianapolis, IN.
  • ,
  • Evgenia Teal, MS

      Affiliations

    • Regenstrief Institute, Indianapolis, IN.
  • ,
  • Siu L. Hui, PhD

      Affiliations

    • Indiana University School of Medicine, Indianapolis, IN
    • Regenstrief Institute, Indianapolis, IN.

Received 15 August 2007; accepted 10 March 2008. published online 28 April 2008.

Background

Hepatitis C and chronic kidney disease (CKD) are both highly prevalent diseases in the United States. Data showed that hepatitis C may be causally linked to some glomerular diseases, and patients who are positive for hepatitis C have increased risk of albuminuria.

Study Design

To determine whether hepatitis C infection is associated with increased likelihood of CKD, we performed retrospective cross-sectional and longitudinal analyses of a large clinical database.

Setting & Participants

Data for a study population of 13,139 African American and white patients tested for hepatitis C between 1994 and 2004 were extracted from a computerized database from a clinical population of an urban hospital and affiliated clinics.

Predictor

Hepatitis C by means of enzyme-linked immunosorbent assay.

Outcome

In cross-sectional analysis, CKD was defined as a minimum estimated glomerular filtration rate (eGFR) less than 60 mL/min/1.73 m2 by using the 4-variable isotope dilution mass spectrometry–traceable Modification of Diet in Renal Disease Study equation or proteinuria. In longitudinal analysis, CKD was defined as eGFR less than 60 mL/min/1.73 m2.

Measurements

Potential confounders investigated included sex, age, race, human immunodeficiency virus (HIV) status, chronic hypertension, diabetes, and other laboratory test result abnormalities.

Results

3,938 patients (30.0%) were positive for hepatitis C and 2,549 (19.4%) had CKD. Of those with CKD, 1,999 (78.4%) had an eGFR less than 60 mL/min/1.73 m2, 186 (7.3%) had proteinuria, and 364 (14.3%) had both. In cross-sectional analysis, after controlling for diabetes, hypertension, age, aspartate aminotransferase level, and HIV status, patients who tested positive for hepatitis C had a decreased risk of CKD (odds ratio, 0.69; 95% confidence interval, 0.62 to 0.77). A total of 7,038 subjects without CKD were followed up for a median of 3.5 years. Of these, 2,243 (31.8%) were hepatitis C positive at the onset of follow-up. In longitudinal analysis, after adjustment for age, baseline eGFR, diabetes, hypertension, aspartate aminotransferase level, and HIV status, the hazard ratio for the development of CKD compared with those who were hepatitis C negative was 0.896 (95% confidence interval, 0.790 to 1.015).

Limitations

Retrospective design, clinical database with missing values, different hepatitis C assays used during the study period, limited data for proteinuria.

Conclusions

Our results do not support the hypothesis that infection with hepatitis C virus per se is associated with increased risk of having or developing CKD.

Index Words: Chronic kidney disease, hepatitis C, proteinuria, glomerular filtration rate

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 30.00 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 Originally published online as doi:10.1053/j.ajkd.2008.03.009 on April 28, 2008.

PII: S0272-6386(08)00583-0

doi:10.1053/j.ajkd.2008.03.009

American Journal of Kidney Diseases
Volume 51, Issue 6 , Pages 885-892, June 2008